March 11, 2025

National Cancer Institute Employees Can’t Publish Information on These Topics Without Special Approval

(ProPublica) – Employees at the National Cancer Institute, which is part of the National Institutes of Health, received internal guidance last week to flag manuscripts, presentations or other communications for scrutiny if they addressed “controversial, high profile, or sensitive” topics. … Read More



 
 

March 10, 2025

Elon Musk’s Neuralink Files to Trademark ‘Telepathy’

(Wired) – Elon Musk’s brain implant company, Neuralink, has filed applications with the United States Patent and Trademark Office (USPTO) to exclusively own the names Telepathy, Telekinesis, and others for future products. Neuralink, which Musk cofounded in 2016, is developing … Read More



 
 

March 7, 2025

Exclusive: US CDC plans study into vaccines and autism, sources say

(Reuters) – The U.S. Centers for Disease Control and Prevention is planning a large study into potential connections between vaccines and autism, two sources familiar with the matter told Reuters, despite extensive scientific research that has disproven or failed to … Read More



 
 

March 3, 2025

Psychedelic drug studies face a potent source of bias: the ‘trip’

(Science) – Innovative trial designs aim to separate participant expectations from drug effects This “functional unblinding” is not unique to psychedelics, but it’s especially pronounced in this drug class. The U.S. Food and Drug Administration (FDA) has expressed concern about … Read More